The new standard in computational neuroscience

Published on: September 10, 2023 | Location: Austin, United States | Tags: Pharmaceuticals & Biotechnology
NeuroX1 is a computational drug design company building a groundbreaking platform to better understand degenerative disorders affecting the brain. We harness the power of Artificial Intelligence (AI) and machine learning (ML) to create the next generation of therapeutics for neurological conditions.